Methodology

All entries for: Augustine Therapeutics NV

August 13, 2025

Augustine Therapeutics NV

Orphan Drug Designation

FDA orphan drug designation: treatment of Charcot-Marie-Tooth (CMT) disease

Disease Area: Rare Diseases
Source
Source
Scroll to Top